Melanoma is not just any skin cancer. It is a dangerous form of skin cancer that can kill if not detected and treated early. Although it can strike at any age, it is one of the most common cancers in young adults. while the incidence of other common cancers is decreasing, the incidence of melanoma has risen alarmingly in recent years.
Some facts about melanoma:
- Melanoma is the most common form of cancer in people aged 25 to 29.
- One person dies from melanoma every hour.
- From 1970 to 2009, the incidence of melanoma increased by 800 percent among young women and 400 percent among young men.
- While it is more common in whites, melanoma is deadlier in blacks and Latinos.
- Melanoma is deadlier in young men than in young women.
- Indoor tanning has been linked with all types of skin cancer, including melanoma.
- One blistering sunburn in childhood or adolescence more than doubles a person's chances of developing melanoma later in life.
About our Foundation:
The White Aisle Foundation was established to honor the life of Rebecca Garrison-Sokoloff, founder and owner of The White Aisle, a successful wedding stationery company. Rebecca died of melanoma on November 13, 2011. The foundation raises funds for melanoma research and patient support, as well as for other charities that Rebecca supported during her life.
The White Aisle Foundation is a 501(c) (3) not-for-profit organization based in Baltimore, Maryland. The foundation helps fund research that will lead to effective treatments and, ultimately, a cure for melanoma; provides education on melanoma prevention and treatment; and supports organizations that provide help with medical expenses to those with melanoma. Honoring the love and concern Rebecca had for the people of Cambodia, the foundation also supports charities that provide housing, education, and health care for children and young women in that country.
In 2013, we began a five-year campaign to raise $100,000 for the Rebecca Garrison Sokoloff Melanoma Research Endowment at Beth Israel Deaconess Medical Center in Boston. The endowment will advance melanoma research and training by directly funding young researchers.